Palladiem’s Oracle ORCL Stock Holding History

Palladiem’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$45.9K	Sell	313 -173	-36%	-$31.4K	0.04%	104
2026 Q1	$67.1K	Hold	486	–	–	0.06%	86
2025 Q4	$95.7K	Buy	+486	New	+$116K	0.09%	80

Other funds holding ORCL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Palladiem's ORCL Position: Q2 2026 in Review

Palladiem reduced its Oracle (ORCL) stake by 36% in Q2 2026, selling an estimated $31.4K and leaving 313 shares worth $45.9K. The position accounts for 0.04% of the portfolio, ranked #104.

Palladiem first reported a position in ORCL in Q4 2025 and has held it in 3 quarters since. The position peaked at $95.7K in Q4 2025. 3,537 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

Palladiem held 313 shares of Oracle worth $45.9K as of Q2 2026.
Palladiem sold 173 Oracle shares in Q2 2026, an estimated $31.4K.
Oracle made up 0.04% of Palladiem's portfolio in Q2 2026, its #104 holding.
Palladiem first reported a position in Oracle in Q4 2025 and has held it in 3 quarters since.
Palladiem's Oracle position peaked at $95.7K in Q4 2025.
3,537 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Palladiem's 13F filing for Q2 2026, filed 13 Aug 2026.